Accenture (ACN) director granted 5 RSUs, now holds 624 shares
Accenture plc (ACN) director Masahiko Uotani reported an equity award in a Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Accenture plc (ACN) director Masahiko Uotani reported an equity award in a Form 4 filing. On 11/14/2025, he acquired 5 Class A ordinary shares in the form of restricted share units (RSUs) at a price of $0, increasing his beneficial ownership to 624 shares held directly. The filing explains that these RSUs were granted under the anti-dilution provisions of earlier RSU awards to reflect Accenture plc's payment of a cash dividend, meaning the grant adjusts prior awards rather than representing a new open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A ordinary shares | 5 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Accenture (ACN) report for Masahiko Uotani?
What is the nature of the equity award reported for Accenture (ACN) director Masahiko Uotani?
Was the Accenture (ACN) insider transaction an open-market purchase or a grant?
Is the Accenture (ACN) Form 4 filed by more than one reporting person?
What type of security did the Accenture (ACN) director receive in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.